{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T11:19:45Z","timestamp":1773832785648,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s12325-025-03454-7","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T07:37:45Z","timestamp":1768203465000},"page":"1109-1128","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prescribing Patterns and Perceptions of Pancreatic Enzyme Replacement Therapy among Healthcare Providers: A Prospective United States Healthcare Providers Survey"],"prefix":"10.1007","volume":"43","author":[{"given":"Motaz","family":"Ashkar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Geremia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zach","family":"Baldwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie Louise","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuehan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viviana","family":"Garcia-Horton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas E.","family":"Dylla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuri","family":"Sanchez Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jodie A.","family":"Barkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"3454_CR1","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2147\/CEG.S168266","volume":"12","author":"G Capurso","year":"2019","unstructured":"Capurso G, Traini M, Piciucchi M, Signoretti M, Arcidiacono PG. Exocrine pancreatic insufficiency: prevalence, diagnosis, and management. Clin Exp Gastroenterol. 2019;12:129\u201339.","journal-title":"Clin Exp Gastroenterol"},{"issue":"5","key":"3454_CR2","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1053\/j.gastro.2023.07.007","volume":"165","author":"DC Whitcomb","year":"2023","unstructured":"Whitcomb DC, Buchner AM, Forsmark CE. AGA clinical practice update on the epidemiology, evaluation, and management of exocrine pancreatic insufficiency: expert review. Gastroenterology. 2023;165(5):1292\u2013301.","journal-title":"Gastroenterology"},{"issue":"39","key":"3454_CR3","doi-asserted-by":"publisher","first-page":"7059","DOI":"10.3748\/wjg.v23.i39.7059","volume":"23","author":"VK Singh","year":"2017","unstructured":"Singh VK, Haupt ME, Geller DE, Hall JA, Diez PMQ. Less common etiologies of exocrine pancreatic insufficiency. World J Gastroenterol. 2017;23(39):7059.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"3454_CR4","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1097\/MOG.0000000000000951","volume":"39","author":"ML Ramsey","year":"2023","unstructured":"Ramsey ML, Hart PA, Forsmark CE. Evaluation and management of exocrine pancreatic insufficiency: pearls and pitfalls. Curr Opin Gastroenterol. 2023;39(5):428\u201335.","journal-title":"Curr Opin Gastroenterol"},{"issue":"1","key":"3454_CR5","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1097\/MPA.0000000000002273","volume":"53","author":"JA Barkin","year":"2024","unstructured":"Barkin JA, Harb D, Kort J, Barkin JS. Real-world patient experience with pancreatic enzyme replacement therapy in the treatment of exocrine pancreatic insufficiency. Pancreas. 2024;53(1):e16\u201321.","journal-title":"Pancreas"},{"issue":"4","key":"3454_CR6","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.pan.2022.03.013","volume":"22","author":"FE de Rijk","year":"2022","unstructured":"de Rijk FE, van Veldhuisen CL, Besselink MG, et al. Diagnosis and treatment of exocrine pancreatic insufficiency in chronic pancreatitis: an international expert survey and case vignette study. Pancreatology. 2022;22(4):457\u201365.","journal-title":"Pancreatology"},{"key":"3454_CR7","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.1002\/ncp.11124","volume":"39","author":"AJ Berry","year":"2024","unstructured":"Berry AJ, Bilbo A. Exocrine pancreatic insufficiency and pancreatic exocrine replacement therapy in clinical practice. Nutr Clin Pract. 2024;39:S78\u201388.","journal-title":"Nutr Clin Pract"},{"key":"3454_CR8","unstructured":"National Institute of Diabetes and Digestive and Kidney Disease. Treatment for Exocrine Pancreatic Insufficiency. 2024. Available from: https:\/\/www.niddk.nih.gov\/health-information\/digestive-diseases\/exocrine-pancreatic-insufficiency\/treatment."},{"key":"3454_CR9","unstructured":"AbbVie. CREON (pancrelipase) delayed\u2010release capsules. 2024. Available from: https:\/\/www.creoninfo.com\/."},{"key":"3454_CR10","unstructured":"Nestl\u00e9 HealthScience. ZENPEP\u00ae (pancrelipase) delayed\u2010release capsules. 2024. Available from: https:\/\/www.zenpep.com\/home-hcp\/about-epi-patients-cf."},{"key":"3454_CR11","unstructured":"Vivus. Medication Guide: PANCREAZE. 2024. Available from: https:\/\/pancreaze.com\/assets\/pdf\/PANCREAZE-Medication-Guide.pdf."},{"key":"3454_CR12","unstructured":"RxList. Viokase. 2024. Available from: https:\/\/www.rxlist.com\/viokase-drug.htm."},{"key":"3454_CR13","unstructured":"Digestive Care Inc. PERTZYE. 2024. Available from: https:\/\/www.pertzye.com\/."},{"key":"3454_CR14","unstructured":"Creon Access & Coverage. 2025. Available from: https:\/\/www.creonhcp.com\/access-coverage."},{"key":"3454_CR15","unstructured":"CF PERT Coverage & Support. 2025. Available from: https:\/\/www.zenpep.com\/home-hcp\/cf-coverage-and-support."},{"key":"3454_CR16","unstructured":"Pancreaze Savings & Support. 2025. Available from: https:\/\/pancreaze.com\/savings-and-support\/."},{"issue":"1","key":"3454_CR17","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1186\/s12913-021-07196-4","volume":"21","author":"K Medlinskiene","year":"2021","unstructured":"Medlinskiene K, Tomlinson J, Marques I, Richardson S, Stirling K, Petty D. Barriers and facilitators to the uptake of new medicines into clinical practice: a systematic review. BMC Health Serv Res. 2021;21(1):1198.","journal-title":"BMC Health Serv Res"},{"key":"3454_CR18","unstructured":"Institute for clinical and economic review. Barriers to fair access assessment. 2025. Available from: https:\/\/icer.org\/wp-content\/uploads\/2024\/06\/Barriers-to-Fair-Access-Final-Research-Protocol-06052024.pdf."},{"key":"3454_CR19","unstructured":"Pan Foundation. HCP Utilization Management. 2025. Available from: https:\/\/www.panfoundation.org\/wp-content\/uploads\/2025\/06\/Utilization-management-patient-impacts-PAN-Foundation-polling-May-2025.pdf."},{"key":"3454_CR20","unstructured":"How do drug plans work? 2025. Available from: https:\/\/www.medicare.gov\/health-drug-plans\/part-d\/what-drug-plans-cover\/how-drug-plans-work."},{"key":"3454_CR21","unstructured":"Patient Advocate Foundation. The Insider's guide to drug formularies & medication benefits. 2025. Available from: https:\/\/education.patientadvocate.org\/wp-content\/uploads\/2024\/07\/Medication-Benefits-and-Formulary-Guide.pdf."},{"key":"3454_CR22","unstructured":"Centers for Medicare & Medicaid Services. CMS releases 2025 Medicare part D bid information and announces premium stabilization demonstration. 2025. Available from: https:\/\/www.cms.gov\/newsroom\/fact-sheets\/cms-releases-2025-medicare-part-d-bid-information-and-announces-premium-stabilization-demonstration."},{"key":"3454_CR23","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2147\/PPA.S24752","volume":"6","author":"CD Barbosa","year":"2012","unstructured":"Barbosa CD, Balp M-M, Kulich K, Germain N, Rofail D. A literature review to explore the link between treatment satisfaction and adherence, compliance, and persistence. Patient Prefer Adherence. 2012;6:39\u201348.","journal-title":"Patient Prefer Adherence"},{"issue":"1","key":"3454_CR24","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3390\/medicina61010153","volume":"61","author":"U Religioni","year":"2025","unstructured":"Religioni U, Barrios-Rodr\u00edguez R, Requena P, Borowska M, Ostrowski J. Enhancing therapy adherence: impact on clinical outcomes, healthcare costs, and patient quality of life. Medicina. 2025;61(1):153.","journal-title":"Medicina"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03454-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-025-03454-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03454-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T08:29:38Z","timestamp":1773822578000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-025-03454-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["3454"],"URL":"https:\/\/doi.org\/10.1007\/s12325-025-03454-7","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"22 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Motaz Ashkar, MBBS, MS: Advisory and consulting for Amgen. Jodie A. Barkin, MD: Scientific advisor for AbbVie, Aimmune therapeutics, Corevitas, Organon, Amgen. Jennifer Geremia MSPAS, PA-C: Advisory board member, speaker and consultant for Madrigal; Advisory board member and speaker for Ipsen and Pfizer; Speaker and consultant for AbbVie; Speaker for Nestle, Lilly and Phathom; Advisory board member for Takeda. Min Yang, MD, Viviana Garcia-Horton, PhD, Marie Louise Edwards, MS,: Employees of Analysis Group, Inc., which has received consulting fees from AbbVie for the conduct of this research. Yuehan Zhang, PhD: Was an employee of Analysis Group, Inc., at the time of the research, which has received consulting fees from AbbVie for the conduct of this research. Dr. Zhang is currently an employee of Johnson and Johnson Innovative Medicine and may own stock. Zach Baldwin, PharmD, Eric Shen, PharmD, Douglas E. Dylla, PhD, Yuri Sanchez Gonzalez, PhD: Employees of AbbVie and may own stock.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All HCPs who confirmed their eligibility to participate consented before proceeding with survey completion. To mitigate against potential bias in the study, HCP respondents remained unaware of the study sponsor, and the sponsors were blinded to the HCPs\u2019 identities. The study was determined to be exempt from institutional review board (IRB) review according to 45 CFR 46.104(d)(2) by Pearl IRB as it involved only the secondary use of data that were de-identified.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}